Back to top
more

Phibro Animal Health (PAHC)

(Real Time Quote from BATS)

$25.02 USD

25.02
105,981

+1.17 (4.91%)

Updated Nov 11, 2024 11:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion

by Zacks Equity Research

Labcorp expands the molecular bioanalytical laboratory in Greenfield, IN.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks to Buy From a Prospective Industry

by Indrajit Bandyopadhyay

Ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, BAX, HAE and PAHC are well-poised to gain from the favorable factors.

TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU

by Zacks Equity Research

Tandem Diabetes' t:slim X2 insulin pump is now compatible with Lilly's Lyumjev in the European Union.

Santanu Roy headshot

Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus

by Santanu Roy

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles

by Zacks Equity Research

Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.

DGX Stock to Benefit From New Partnership With Sentara Health Plans

by Zacks Equity Research

Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.

TMO Stock to Gain From Expanded Bioanalytical Services in Sweden

by Zacks Equity Research

Thermo Fisher's PPD arm unveils a new facility in Sweden, expanding its bioanalytical capabilities.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

PAHC vs. ABT: Which Stock Is the Better Value Option?

by Zacks Equity Research

PAHC vs. ABT: Which Stock Is the Better Value Option?

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA

by Zacks Equity Research

Charles River collaborates with CEBINA as part of the DanubeNeuro program to advance innovation in neurodegeneration.

Is Phibro Stock Worth Retaining in Your Portfolio Now?

by Zacks Equity Research

PAHC Animal Health business, supported by the flourishing vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.

PAHC Stock Gains From Innovation, Market Expansion Goal

by Zacks Equity Research

Phibro Animal Health's nutritional product offerings, such as OmniGen-AF and Animate, are being increasingly used in the global dairy industry.

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) is a Great Choice

by Zacks Equity Research

Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Implied Volatility Surging for Phibro Animal Health (PAHC) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Phibro Animal Health (PAHC) stock based on the movements in the options market lately.

PAHC vs. ABT: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PAHC vs. ABT: Which Stock Is the Better Value Option?

Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Phibro (PAHC) International Revenue Performance Explored

by Zacks Equity Research

Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Phibro Q4 Earnings and Revenues Beat, Operating Margin Down

by Zacks Equity Research

PAHC's impressive fourth-quarter fiscal 2024 results can be attributed to the Animal Health segment's robust performance.

Here's What Key Metrics Tell Us About Phibro (PAHC) Q4 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Phibro Animal Health (PAHC) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Phibro (PAHC) delivered earnings and revenue surprises of 20.59% and 4.09%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Phibro (PAHC) Stock Jumps 10.2%: Will It Continue to Soar?

by Zacks Equity Research

Phibro (PAHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Broad Portfolio to Aid Patterson Companies' (PDCO) Q1 Earnings

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments on the back of comprehensive product offerings.

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.